Both in Biotechnology
Dyadic International vs Acumen Pharmaceuticals
Over the past year DYAI returned −66.7% and ABOS returned −89.2%; their daily moves had a correlation of -0.02.
DYAI −66.7% ABOS −89.2%Growth of $1, one year, split-adjusted
| Metric | DYAI | ABOS |
|---|---|---|
| Price | $0.3600 | $0.2344 |
| Market cap | $14.4M | $17.0M |
| Today | −4.26% | −2.21% |
| 1 month | −20.7% | −89.0% |
| 6 months | −53.3% | −90.7% |
| Year to date | −61.7% | −88.9% |
| 1 year | −68.1% | −89.4% |
| Revenue growth (YoY) | −0.6% | — |
| Gross margin | −2.4% | — |
| Net margin | −221.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.8× | — |
| Net cash | -$1.9M | $52.3M |
| Dividend yield | — | — |
| Volatility (60d) | 77.8% | 493.0% |
| Short % of float | 0.7% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).